Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overview All 13F holders of BCRX Full Q2 2022 holdings

Shares (Q2 2022): 32
Value: $338
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2021

Holdings of BCRX by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	32	$338	<0.1%	−7,495−99.6%	Reduced	Holders
Q1 2022	7,527	$122.4K	<0.1%	−3,819−33.7%	Reduced	Holders
Q4 2021	11,346	$157.1K	<0.1%	+4,727+71.4%	Added	Holders
Q3 2021	6,619	$95.1K	<0.1%	+6,619	New	Holders